Randomized phase II trial of CODE or AP after chemoradiotherapy for LD-SCLC: Long-term survival and toxicity analysis

Annals of Oncology ◽

10.1093/annonc/mdz264.005 ◽

2019 ◽

Vol 30 ◽

pp. v712

Author(s):

Sekine ◽

H. Harada ◽

N. Yamamoto ◽

M. Wakabayashi ◽

H. Murakami ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii ◽

Toxicity Analysis

Download Full-text

IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA

Neuro-Oncology ◽

10.1093/neuonc/nov218.08 ◽

2015 ◽

Vol 17 (suppl 5) ◽

pp. v109.1-v109 ◽

Author(s):

David A. Reardon ◽

Annick Desjardins ◽

James Schuster ◽

David D. Tran ◽

Karen L. Fink ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii

Download Full-text

Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.3501 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 3501-3501 ◽

Author(s):

Theo Ruers ◽

Cornelis J. A. Punt ◽

Frits van Coevorden ◽

Jean-Pierre Pierie ◽

Inne Borel Rinkes ◽

...

Keyword(s):

Radiofrequency Ablation ◽

Liver Metastases ◽

Phase Ii ◽

Colorectal Liver Metastases ◽

Phase Ii Study ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii ◽

Unresectable Colorectal Liver Metastases

Download Full-text

Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19009 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19009-19009

Author(s):

G. Q. Chen ◽

M. Huynh ◽

L. Fehrenbacher ◽

A. M. Davies ◽

H. West ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Term Survival ◽

Long Term Survival

Download Full-text

Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival

Hematology/Oncology and Stem Cell Therapy ◽

10.5144/1658-3876.2012.152 ◽

2012 ◽

Vol 5 (3) ◽

pp. 152-157 ◽

Author(s):

Henry L. Gómez ◽

César Samanéz ◽

Frank Campana ◽

Silvia P. Neciosup ◽

Luis Vera ◽

...

Keyword(s):

Elderly Patients ◽

Hodgkin Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Chop Regimen ◽

Term Survival ◽

Long Term Survival ◽

Non Hodgkin Lymphoma

Download Full-text

WITHDRAWN: Addition of amifostine to CHOP regimen significantly reduced toxicity in patients with aggressive non-Hodgkin’s lymphoma without affecting the long term survival: Results of a phase II trial

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2012.10.001 ◽

2013 ◽

Author(s):

Henry L. Gómez

Keyword(s):

Phase Ii ◽

Hodgkin’S Lymphoma ◽

Phase Ii Trial ◽

Hodgkin's Lymphoma ◽

Chop Regimen ◽

Term Survival ◽

Long Term Survival ◽

Non Hodgkin's Lymphoma ◽

Reduced Toxicity

Download Full-text

Long term survival in IMAGE 1 (Immune Modulation And Gemcitabine Evaluation 1), a randomized, open-label phase II trial comparing gemcitabine with and without IMM-101 in advanced pancreatic cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.3051 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 3051-3051

Author(s):

Angus George Dalgleish ◽

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Immune Modulation ◽

Phase Ii Trial ◽

Advanced Pancreatic Cancer ◽

Term Survival ◽

Long Term Survival ◽

Open Label Phase

Download Full-text

Final Analysis on Long-term Survival and Late Toxicities for a Randomized Phase II Study of Cisplatin/5-FU Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG-0101, JROSG-021)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.708 ◽

2010 ◽

Vol 78 (3) ◽

pp. S297-S298

Author(s):

Y. Nishimura ◽

M. Mitsumori ◽

M. Hiraoka ◽

R. Koike ◽

K. Nakamatsu ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Final Analysis ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii

Download Full-text

Predictors of Long-Term Survival in Patients with Lung Cancer Included in the Randomized Spanish Lung Cancer Group 0008 Phase II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy

Clinical Lung Cancer ◽

10.3816/clc.2009.n.025 ◽

2009 ◽

Vol 10 (3) ◽

pp. 180-186 ◽

Author(s):

Pilar Garrido ◽

Rafael Rosell ◽

Bartomeu Massutí ◽

Felipe Cardenal ◽

Vicente Alberola ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Consolidation Chemotherapy ◽

Term Survival ◽

Long Term Survival ◽

Cancer Group ◽

Concomitant Chemoradiation

Download Full-text

Predictors of long-term survival in lung cancer patients (p) included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel (D) and carboplatin (Cb) plus induction (I) or consolidation (C) chemotherapy (CT) with docetaxel and gemcitabine (G)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7574 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7574-7574

Author(s):

P. Garrido Lopez ◽

R. Rosell ◽

B. Massutí ◽

F. Cardenal ◽

V. Alberola Candel ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Term Survival ◽

Long Term Survival ◽

Lung Cancer Patients ◽

Cancer Group ◽

Concomitant Chemoradiation

Download Full-text

Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-0935 ◽

2007 ◽

Vol 13 (22) ◽

pp. 6696-6702 ◽

Author(s):

Fabienne Iten ◽

Beat Müller ◽

Christian Schindler ◽

Christoph Rochlitz ◽

Daniel Oertli ◽

...

Keyword(s):

Clinical Trial ◽

Thyroid Cancer ◽

Phase Ii ◽

Survival Benefit ◽

Medullary Thyroid Cancer ◽

Phase Ii Clinical Trial ◽

Term Survival ◽

Long Term Survival ◽

Medullary Thyroid

Download Full-text